A DOUBLE-BLIND CROSSOVER PILOT-STUDY OF L-DEPRENYL (SELEGILINE) COMBINED WITH CHOLINESTERASE INHIBITOR IN ALZHEIMERS-DISEASE

被引：0
|
作者：
SCHNEIDER, LS [1 ]
OLIN, JT [1 ]
PAWLUCZYK, S [1 ]
机构：
[1] UNIV SO CALIF,SCH MED,DEPT PSYCHIAT & BEHAV SCI,LOS ANGELES,CA 90033
来源：
AMERICAN JOURNAL OF PSYCHIATRY | 1993年 / 150卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
The potential efficacy of oral 1-deprenyl (5 mg b.i.d.) added to the regimen of 10 patients with Alzheimer's disease receiving either tacrine or physostigmine was assessed in a double-blind, placebo-controlled, 4-week, two-period crossover pilot study. 1-Deprenyl was associated with significant improvement in scores on the cognitive subscale of the Alzheimer's Disease Assessment Scale, suggesting possible additive effects of 1-deprenyl to the effects of cholinesterase inhibitors.
引用
收藏
页码：321 / 323
页数：3
相关论文
共 50 条
  • [21] SELEGILINE (1-DEPRENYL) AND LOW-DOSE LEVODOPA TREATMENT OF PARKINSONS-DISEASE - A DOUBLE-BLIND CROSSOVER TRIAL
    PRESTHUS, J
    BERSTAD, J
    LIEN, K
    ACTA NEUROLOGICA SCANDINAVICA, 1987, 76 (03): : 200 - 203
  • [22] A DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTER STUDY OF TACRINE FOR ALZHEIMERS-DISEASE
    WOOD, PC
    NEUROBIOLOGY OF AGING, 1994, 15 : S99 - S100
  • [23] A DOUBLE-BLIND, PLACEBO-CONTROLLED MULTICENTER STUDY OF TACRINE FOR ALZHEIMERS-DISEASE
    DAVIS, KL
    THAL, LJ
    GAMZU, ER
    DAVIS, CS
    WOOLSON, RF
    GRACON, SI
    DRACHMAN, DA
    SCHNEIDER, LS
    WHITEHOUSE, PJ
    HOOVER, TM
    MORRIS, JC
    KAWAS, CH
    KNOPMAN, DS
    EARL, NL
    KUMAR, V
    DOODY, RS
    NEW ENGLAND JOURNAL OF MEDICINE, 1992, 327 (18): : 1253 - 1259
  • [24] A DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTER STUDY OF TACRINE FOR ALZHEIMERS-DISEASE
    WOOD, PC
    CASTLEDEN, CM
    INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY, 1994, 9 (08) : 649 - 654
  • [25] APPLIED KINESIOLOGY - DOUBLE-BLIND PILOT-STUDY
    FRIEDMAN, MH
    WEISBERG, J
    JOURNAL OF PROSTHETIC DENTISTRY, 1981, 45 (03): : 321 - 323
  • [26] DOUBLE-BLIND TRIAL OF 2-DIMETHYLAMINOETHANOL IN ALZHEIMERS-DISEASE
    FISMAN, M
    MERSKY, H
    HELMES, E
    AMERICAN JOURNAL OF PSYCHIATRY, 1981, 138 (07): : 970 - 972
  • [27] POSITRON EMISSION TOMOGRAPHY AND FAMILIAL ALZHEIMERS-DISEASE - A PILOT-STUDY
    GUZE, BH
    HOFFMAN, JM
    MAZZIOTTA, JC
    BAXTER, LR
    PHELPS, ME
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 1992, 40 (02) : 120 - 123
  • [28] TRIAZOLAM IN ALZHEIMERS-DISEASE - PILOT-STUDY ON SLEEP AND MEMORY EFFECTS
    MCCARTEN, JR
    KOVERA, C
    MADDOX, MK
    CLEARY, JP
    PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1995, 52 (02) : 447 - 452
  • [29] L-DEPRENYL IN ALZHEIMERS-DISEASE - PRELIMINARY EVIDENCE FOR BEHAVIORAL-CHANGE WITH MONOAMINE OXIDASE-B INHIBITION
    TARIOT, PN
    COHEN, RM
    SUNDERLAND, T
    NEWHOUSE, PA
    YOUNT, D
    MELLOW, AM
    WEINGARTNER, H
    MUELLER, EA
    MURPHY, DL
    ARCHIVES OF GENERAL PSYCHIATRY, 1987, 44 (05) : 427 - 433
  • [30] DOUBLE-BLIND TRIAL OF IMIPRAMINE IN ALZHEIMERS-DISEASE PATIENTS WITH AND WITHOUT DEPRESSION
    REIFLER, BV
    TERI, L
    RASKIND, M
    VEITH, R
    BARNES, R
    WHITE, E
    MCLEAN, P
    AMERICAN JOURNAL OF PSYCHIATRY, 1989, 146 (01): : 45 - 49
12345